Paper23201840
Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea.
Du GJ and 6 others. Nutrients, 2012. Cited by 332 papers, by iCite.
Cite this record
ConductScience Library. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Papers, record 23201840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23201840
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticarcinogenic Agents | Major topic |
| Catechin | Major topic |
| Polyphenols | Major topic |
| Tea | Major topic |
| Apoptosis | |
| Cell Cycle Checkpoints | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Colorectal Neoplasms | |
| HCT116 Cells | |
| Humans | |
| Models, Molecular | |
| Molecular Structure | |
| Structure-Activity Relationship |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 AT005362 | NCCIH NIH HHS | United States | K01AT005362 | PubMed and NIH | NIH RePORTER |
| P01 AT004418 | NCCIH NIH HHS | United States | P01AT004418 | PubMed and NIH | NIH RePORTER |
| P01 AT 004418 | NCCIH NIH HHS | United States | P01AT004418 | PubMed and NIH | NIH RePORTER |
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21213395 | Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. | Am J Chin Med | 2011 | https://conductscience.org/library/papers/21213395 | PubMed |
| 2 | 15797997 | Apoptosis-based therapies for hematologic malignancies. | Blood | 2005 | https://conductscience.org/library/papers/15797997 | PubMed |
| 3 | 22083982 | Anticancer activity of Nigella sativa (black seed) - a review. | Am J Chin Med | 2011 | https://conductscience.org/library/papers/22083982 | PubMed |
| 4 | 22809022 | Herbal medicines as adjuvants for cancer therapeutics. | Am J Chin Med | 2012 | https://conductscience.org/library/papers/22809022 | PubMed |
| 5 | 17009031 | Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. | Cancer Chemother Pharmacol | 2007 | https://conductscience.org/library/papers/17009031 | PubMed |
| 6 | 21194832 | Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. | Cancer Lett | 2011 | https://conductscience.org/library/papers/21194832 | PubMed |
| 7 | 22237781 | Cancer statistics, 2012. | CA Cancer J Clin | 2012 | https://conductscience.org/library/papers/22237781 | PubMed |
| 8 | 22626556 | Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention. | Cancer Lett | 2012 | https://conductscience.org/library/papers/22626556 | PubMed |
| 9 | 22784609 | Role of antioxidants in cancer therapy. | Nutrition | 2013 | https://conductscience.org/library/papers/22784609 | PubMed |
| 10 | 21827739 | Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. | Biochem Pharmacol | 2011 | https://conductscience.org/library/papers/21827739 | PubMed |
| 11 | 17575143 | Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. | Cancer Res | 2007 | https://conductscience.org/library/papers/17575143 | PubMed |
| 12 | 17127241 | Green tea polyphenols in the prevention of colon cancer. | Front Biosci | 2007 | https://conductscience.org/library/papers/17127241 | PubMed |
| 13 | 16115949 | Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16115949 | PubMed |
| 14 | 20558130 | The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. | Arch Biochem Biophys | 2010 | https://conductscience.org/library/papers/20558130 | PubMed |
| 15 | 22566066 | The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells. | Phytother Res | 2013 | https://conductscience.org/library/papers/22566066 | PubMed |
| 16 | 17255296 | Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17255296 | PubMed |
| 17 | 19839593 | Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies. | J Med Chem | 2009 | https://conductscience.org/library/papers/19839593 | PubMed |
| 18 | 21721147 | Botanical flavonoids on coronary heart disease. | Am J Chin Med | 2011 | https://conductscience.org/library/papers/21721147 | PubMed |
| 19 | 19715726 | Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. | Prog Lipid Res | 2010 | https://conductscience.org/library/papers/19715726 | PubMed |
| 20 | 17145898 | Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. | Cancer Res | 2006 | https://conductscience.org/library/papers/17145898 | PubMed |
Cited by189
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 332 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940254 | The Chromomethylase CsCMT2 Negatively Affects Catechin Accumulation in Tea Plants. | Foods | 2026 | https://conductscience.org/library/papers/42940254 | PubMed |
| 42724533 | Epigallocatechin gallate is associated with PDGFRB downregulation and altered PI3K-AKT signaling in gastric cancer. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724533 | PubMed |
| 42294073 | Production of Instant Linden Tea (Tilia spp.) Powder: Integrating Compound-Level Infusion Kinetics With Response Surface-Optimized Spray Drying. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42294073 | PubMed |
| 42072404 | Metabolic Amplification in Endometrial Carcinogenesis: Biological Rationale and Translational Limits of Precision Chemoprevention. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072404 | PubMed |
| 41892571 | Next-Generation Hydrogels Integrating Natural Antioxidants and Microbiome Modulators for Improved Cancer Management. | Gels | 2026 | https://conductscience.org/library/papers/41892571 | PubMed |
| 41294811 | The Potential of Bioactive Plant Phytochemicals, Pro-Resolving Anti-Inflammatory Lipids, and Statins in the Inhibition of Intervertebral Disc Degeneration, Low Back Pain Resolution, Disc Functional Repair, and Promotion of Intervertebral Disc Regeneration. | Cells | 2025 | https://conductscience.org/library/papers/41294811 | PubMed |
| 41009660 | The Roles of Moonlighting Nicotinamide Mononucleotide Adenylyl Transferases in Cell Physiology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009660 | PubMed |
| 40725242 | Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725242 | PubMed |
| 40607631 | The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential. | Cancer Med | 2025 | https://conductscience.org/library/papers/40607631 | PubMed |
| 40512223 | Identification of potential human targets for epigallocatechin gallate through a novel protein binding site screening approach. | J Mol Model | 2025 | https://conductscience.org/library/papers/40512223 | PubMed |
| 40426970 | Reduced Expression of UPRmt Proteins HSP10, HSP60, HTRA2, OMA1, SPG7, and YME1L Is Associated with Accelerated Heart Failure in Humans. | Biomedicines | 2025 | https://conductscience.org/library/papers/40426970 | PubMed |
| 40356992 | Harnessing nutrients and natural products for sustainable drug development against aging. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40356992 | PubMed |
| 40281695 | Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40281695 | PubMed |
| 40248930 | Anti-cancer Properties of Epigallocatechin-3-gallate (EGCG) and its Signaling Pathways. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/40248930 | PubMed |
| 40200651 | Pomegranate Extracts as Dual Regulators of Angiogenesis: A Systematic Review of Preclinical Evidence in Cancer and Chronic Wound Healing. | Mol Nutr Food Res | 2025 | https://conductscience.org/library/papers/40200651 | PubMed |
| 40004944 | Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms. | Nutrients | 2025 | https://conductscience.org/library/papers/40004944 | PubMed |
| 39974540 | Study on the regulation of tea polyphenols on the structure and gel properties of myofibrillar protein from Neosalanx taihuensis. | Food Chem X | 2025 | https://conductscience.org/library/papers/39974540 | PubMed |
| 39942757 | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential. | Molecules | 2025 | https://conductscience.org/library/papers/39942757 | PubMed |
| 39852004 | Cordyceps militaris-Derived Bioactive Gels: Therapeutic and Anti-Aging Applications in Dermatology. | Gels | 2025 | https://conductscience.org/library/papers/39852004 | PubMed |
| 39744134 | Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39744134 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23201840
GET https://conductscience.org/api/papers/v1/23201840/references?page=2